Suchergebnisse - TSANTOULIS, PETROS
- Treffer 1 - 20 von 21
- Zur nächsten Seite
-
1
-
2
The Landscape of Immunotherapy Resistance in NSCLC von Frisone, Daniele, Friedlaender, Alex, Addeo, Alfredo, Tsantoulis, Petros
Veröffentlicht 2022Text -
3
-
4
Are common fragile sites merely structural domains or highly organized “functional” units susceptible to oncogenic stress? von Georgakilas, Alexandros G., Tsantoulis, Petros, Kotsinas, Athanassios, Michalopoulos, Ioannis, Townsend, Paul, Gorgoulis, Vassilis G.
Veröffentlicht 2014Text -
5
-
6
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation von Terzic, Julie, Seipel, Amanda, Dubuisson, Jean, Tille, Jean-Christophe, Tsantoulis, Petros, Addeo, Alfredo, Labidi-Galy, S.Intidhar
Veröffentlicht 2020Text -
7
Structure-based prediction of BRAF mutation classes using machine-learning approaches von Krebs, Fanny S., Britschgi, Christian, Pradervand, Sylvain, Achermann, Rita, Tsantoulis, Petros, Haefliger, Simon, Wicki, Andreas, Michielin, Olivier, Zoete, Vincent
Veröffentlicht 2022Text -
8
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma von Marinari, Eliana, Allard, Mathilde, Gustave, Robin, Widmer, Valérie, Philippin, Géraldine, Merkler, Doron, Tsantoulis, Petros, Dutoit, Valérie, Dietrich, Pierre-Yves
Veröffentlicht 2020Text -
9
Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread von Marinari, Eliana, Dutoit, Valerie, Nikolaev, Sergey, Vargas, Maria-Isabel, Schaller, Karl, Lobrinus, Johannes Alexander, Dietrich, Pierre-Yves, Tsantoulis, Petros, Migliorini, Denis
Veröffentlicht 2021Text -
10
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer von Ballestrero, Alberto, Bedognetti, Davide, Ferraioli, Domenico, Franceschelli, Paola, Labidi-Galy, Sana Intidhar, Leo, Elisabetta, Murai, Junko, Pommier, Yves, Tsantoulis, Petros, Vellone, Valerio Gaetano, Zoppoli, Gabriele
Veröffentlicht 2017Text -
11
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss von Frisone, Daniele, Charrier, Melinda, Clement, Sophie, Christinat, Yann, Thouvenin, Laure, Homicsko, Krisztian, Michielin, Olivier, Bodmer, Alexandre, Chappuis, Pierre O., McKee, Thomas A., Tsantoulis, Petros
Veröffentlicht 2019Text -
12
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma von Tsantoulis, Petros, Delorenzi, Mauro, Bièche, Ivan, Vacher, Sophie, Mariani, Pascale, Cassoux, Nathalie, Houy, Alexandre, Stern, Marc-Henri, Roman-Roman, Sergio, Dietrich, Pierre-Yves, Roth, Arnaud, Cacheux, Wulfran
Veröffentlicht 2019Text -
13
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab von Thouvenin, Laure, Charrier, Mélinda, Clement, Sophie, Christinat, Yann, Tille, Jean-Christophe, Frigeri, Mauro, Homicsko, Krisztian, Michielin, Olivier, Bodmer, Alexandre, Chappuis, Pierre O., McKee, Thomas A., Tsantoulis, Petros
Veröffentlicht 2021Text -
14
Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer von Tsoli, Efthimia, Tsantoulis, Petros K, Papalambros, Alexandros, Perunovic, Branko, England, David, Rawlands, David A, Reynolds, Gary M, Vlachodimitropoulos, Dimitrios, Morgan, Susan L, Spiliopoulou, Chara A, Athanasiou, Thanos, Gorgoulis, Vassilis G
Veröffentlicht 2007Text -
15
Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospe... von Bamias, Aristotle, Tsantoulis, Petros, Zilli, Thomas, Papatsoris, Athanasios, Caparrotti, Francesca, Kyratsas, Christos, Tzannis, Kimon, Stravodimos, Kostas, Chrisofos, Michael, Wirth, Gregory J., Skolarikos, Andreas, Mitropoulos, Dionysios, Constantinides, Constantinos A., Deliveliotis, Charalambos, Iselin, Christophe E., Miralbell, Raymond, Dietrich, Pierre‐Yves, Dimopoulos, Meletios A.
Veröffentlicht 2016Text -
16
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences von Cacheux, Wulfran, Tsantoulis, Petros, Briaux, Adrien, Vacher, Sophie, Mariani, Pascale, Richard‐Molard, Marion, Buecher, Bruno, Richon, Sophie, Jeannot, Emmanuelle, Lazartigues, Julien, Rouleau, Etienne, Mariani, Odette, El Alam, Elsy, Cros, Jérôme, Roman‐Roman, Sergio, Mitry, Emmanuel, Girard, Elodie, Dangles‐Marie, Virginie, Lièvre, Astrid, Bièche, Ivan
Veröffentlicht 2018Text -
17
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors von Elias, Kevin M., Tsantoulis, Petros, Tille, Jean-Christophe, Vitonis, Allison, Doyle, Leona A., Hornick, Jason L., Kaya, Gurkan, Barnes, Laurent, Cramer, Daniel W, Puppa, Giacomo, Stuckelberger, Sarah, Hooda, Jagmohan, Dietrich, Pierre-Yves, Goggins, Michael, Kerr, Candace L., Birrer, Michael, Hirsch, Michelle S., Drapkin, Ronny, Labidi-Galy, S. Intidhar
Veröffentlicht 2018Text -
18
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection von Cacheux, Wulfran, Rouleau, Etienne, Briaux, Adrien, Tsantoulis, Petros, Mariani, Pascale, Richard-Molard, Marion, Buecher, Bruno, Dangles-Marie, Virginie, Richon, Sophie, Lazartigues, Julien, Jeannot, Emmanuelle, Farkhondeh, Fereshteh, Sastre-Garau, Xavier, de La Rochefordière, Anne, Labib, Alain, Falcou, Marie-Christine, Stevens, Denise, Roth, Arnaud, Roman-Roman, Sergio, Mitry, Emmanuel, Bièche, Ivan, Lièvre, Astrid
Veröffentlicht 2016Text -
19
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis von Leach, Joshua D. G., Vlahov, Nikola, Tsantoulis, Petros, Ridgway, Rachel A., Flanagan, Dustin J., Gilroy, Kathryn, Sphyris, Nathalie, Vázquez, Ester G., Vincent, David F., Faller, William J., Hodder, Michael C., Raven, Alexander, Fey, Sigrid, Najumudeen, Arafath K., Strathdee, Douglas, Nixon, Colin, Hughes, Mark, Clark, William, Shaw, Robin, van Hooff, Sander R., Huels, David J., Medema, Jan Paul, Barry, Simon T., Frame, Margaret C., Unciti-Broceta, Asier, Leedham, Simon J., Inman, Gareth J., Jackstadt, Rene, Thompson, Barry J., Campbell, Andrew D., Tejpar, Sabine, Sansom, Owen J.
Veröffentlicht 2021Text -
20
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia von Decroocq, Justine, Birsen, Rudy, Montersino, Camille, Chaskar, Prasad, Mano, Jordi, Poulain, Laury, Friedrich, Chloe, Alary, Anne-Sophie, Guermouche, Helene, Sahal, Ambrine, Fouquet, Guillemette, Gotanègre, Mathilde, Simonetta, Federico, Mouche, Sarah, Gestraud, Pierre, Lescure, Auriane, Del Nery, Elaine, Bosc, Claudie, Grenier, Adrien, Mazed, Fetta, Mondesir, Johanna, Chapuis, Nicolas, Ho, Liza, Boughalem, Aicha, Lelorc’h, Marc, Gobeaux, Camille, Fontenay, Michaela, Recher, Christian, Vey, Norbert, Guillé, Arnaud, Birnbaum, Daniel, Hermine, Olivier, Radford-Weiss, Isabelle, Tsantoulis, Petros, Collette, Yves, Castellano, Rémy, Sarry, Jean-Emmanuel, Pasmant, Eric, Bouscary, Didier, Kosmider, Olivier, Tamburini, Jerome
Veröffentlicht 2022Text